REGISTRATION COMING SOON!

POET International Congress

Arthur J.E. Child Comprehensive Cancer Centre, Calgary, AB

WELCOME

April 1 & 2, 2027

We are very pleased to welcome back the Annual International POET Congress, which will be held at its new location the Arthur J.E. Child Comprehensive Cancer Centre in Calgary, AB on April 1 & 2, 2027.

The POET Congress has been held annually since 2017 with great success. The feedback received from last year’s congress, along with the monthly POET National Virtual Molecular Rounds confirms an increased interest in cutting-edge precision oncology education programs.

The objective of the 2027 International POET Congress is to create a forum for dialogue between oncologists, researchers, biopharma leaders, data analysts and clinical trialists.

Attendees will gain insights from world-renowned scientists on cutting-edge biomarker research, design and execution of precision clinical trials, latest advances in immune-oncology and microbiome research, applications of AI in oncology and the use of liquid biopsies in monitoring disease progression and treatment decision-making.

Thank you and we look forward to welcoming you to the 2027 POET Congress!

Sincerely,

POET Co-Chairs

Dr. Pinaki Bose
POET Scientific Lead
Associate Professor, Departments of Oncology, Biochemistry & Molecular Biology
Director, Tumour Biology & Translational Research Ohlson Research Initiative
Arnie Charbonneau Cancer Institute University of Calgary
Calgary, AB

Dr. Steven Yip
POET Medical Lead
Clinical Associate Professor
Department of Oncology, Cumming School of Medicine
Tom Baker Cancer Centre
Calgary, AB

Program Learning objectives are as follows:

As a result of attending this congress the participant will be able to:

  • Identify and interpret emerging multi-omic biomarkers to inform optimal treatment strategies
    involving immune-therapeutics and targeted therapies in cancer care.
  • Apply key principles of precision oncology clinical trial design, including patient stratification,
    biomarker-driven enrollment, and adaptive methodologies.
  • Evaluate the challenges and opportunities in implementing precision oncology within traditional
    healthcare systems, including regulatory, infrastructural, and equity considerations.
REGISTER FOR POET CONGRESS!

Program Learning objectives are as follows:

As a result of attending this congress the participant will be able to:

  • Identify and interpret emerging multi-omic biomarkers to inform optimal treatment strategies
    involving immune-therapeutics and targeted therapies in cancer care.
  • Apply key principles of precision oncology clinical trial design, including patient stratification,
    biomarker-driven enrollment, and adaptive methodologies.
  • Evaluate the challenges and opportunities in implementing precision oncology within traditional
    healthcare systems, including regulatory, infrastructural, and equity considerations.